Hypermethylation of PDX1, EN2, and MSX1 predicts the prognosis of colorectal cancer
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q1Scopus Q1KCI Q4
- 저널
- Experimental and Molecular Medicine54(2) · pp.156 · 2022
- 피인용
- Web of Science 20Scopus 23KCI 0
- FWCI (Scopus)
- 1.56
- JCR IF
- JCR 2021 12.172
- ISSN
- 1226-3613
저자
- Lee, Yeongun제1저자Yonsei Univ, Gangnam Severance Hosp, Grad Sch Med Sci, Severance Biomed Sci Inst,Coll Med,Brain Korea 21, Seoul, South Korea
- Dho, So HeeYonsei Univ, Gangnam Severance Hosp, Grad Sch Med Sci, Severance Biomed Sci Inst,Coll Med,Brain Korea 21, Seoul, South Korea
- Lee, JiyeonYonsei Univ, Gangnam Severance Hosp, Grad Sch Med Sci, Severance Biomed Sci Inst,Coll Med,Brain Korea 21, Seoul, South Korea
- Hwang, Ji-HyunYonsei Univ, Grad Sch, Interdisciplinary Program Integrated OMICS Biomed, Seoul, South Korea
- Kim, MinjungYonsei Univ, Grad Sch, Interdisciplinary Program Integrated OMICS Biomed, Seoul, South Korea
- Choi, Won-YoungYonsei Univ, Grad Sch, Interdisciplinary Program Integrated OMICS Biomed, Seoul, South Korea
- Lee, Jin-YoungYonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea
- Lee, JongwonKorea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea
- 장우철Pusan Natl Univ, Coll Educ, Dept Biol Educ, Busan, South Korea
- Lee, Min YoungKyungpook Natl Univ, Coll Pharm, Vessel Organ Interact Res Ctr MRC, Res Inst Pharmaceut Sci, Daegu, South Korea
- Choi, JungminKorea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea
- Kim, Tae-You교신저자Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Canc Res Inst,Seoul Natl Univ Hosp, Dept Mol Med & Biopharmaceut Sci,Dept Internal Me, Seoul, South Korea
- Kim, Lark Kyun교신저자Yonsei Univ, Gangnam Severance Hosp, Grad Sch Med Sci, Severance Biomed Sci Inst,Coll Med,Brain Korea 21, Seoul, South Korea
초록
© 2022, The Author(s).Despite numerous observations regarding the relationship between DNA methylation changes and cancer progression, only a few genes have been verified as diagnostic biomarkers of colorectal cancer (CRC). To more practically detect methylation changes, we performed targeted bisulfite sequencing. Through co-analysis of RNA-seq, we identified cohort-specific DNA methylation markers: CpG islands of the intragenic regions of PDX1, EN2, and MSX1. We validated that these genes have oncogenic features in CRC and that their expression levels are increased in correlation with the hypermethylation of intragenic regions. The reliable depth of the targeted bisulfite sequencing data enabled us to design highly optimized quantitative methylation-specific PCR primer sets that can successfully detect subtle changes in the methylation levels of candidate regions. Furthermore, these methylation levels can divide CRC patients into two groups denoting good and poor prognoses. In this study, we present a streamlined workflow for screening clinically significant differentially methylated regions. Our discovery of methylation markers in the PDX1, EN2, and MSX1 genes suggests their promising performance as prognostic markers and their clinical application in CRC patients.
키워드
식별자
- Scopus EID
- 2-s2.0-85124749867
- WoS UID
- 000755448200002
- KCI
- ART002816959



로그인
연구물 목록으로